Postlung Transplant Survival is Equivalent Regardless of Cytomegalovirus Match Status

Annals of Thoracic Surgery

Volumn 84, Issue 4, 2007, Pages 1129-1135

  Russo, Mark J ^a   Sternberg, David I ^a   Hong, Kimberly N ^a   Sorabella, Robert A ^a   Moskowitz, Alan J ^a   Gelijns, Annetine C ^a   Wilt, Jessie R ^b   D'Ovidio, Frank ^a   Kawut, Steve M ^b   Arcasoy, Selim M ^b   Sonett, Joshua R ^a  

^a Intl Ctr Hlth Outcomes/Innov R   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GRAFT RECIPIENT; HUMAN; LOG RANK TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEROLOGY; SURVIVAL; TREATMENT OUTCOME;

COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 34548775749     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.05.037     Document Type: Article

References (15)

1. Limaye A.P., Raghu G., Koelle D.M., Ferrenberg J., Huang M.L., and Boeckh M. High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 185 (2002) 20-27
2. Bonatti H., Tabarelli W., Ruttmann E., et al. Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Am Surg 70 (2004) 710-714
3. Bando K., Paradis I.L., Komatsu K., et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 109 (1995) 49-59
4. Smith M.A., Sundaresan S., Mohanakumar T., et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 116 (1998) 812-820
5. Ganesh J.S., Rogers C.A., Banner N.R., Bonser R.S., and Steering Group of the UK Cardiothoracic Transplant Audit. Donor cause of death and mid-term survival in lung transplantation. J Heart Lung Transplant 24 (2005) 1544-1549
6. Heng D., Sharples L.D., McNeil K., Stewart S., Wreghitt T., and Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263
7. Tamm M., Aboyoun C.L., Chhajed P.N., Rainer S., Malouf M.A., and Glanville A.R. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 170 (2004) 1120-1123 (Epub 2004 Aug 5)
8. Luckraz H., Sharples L., McNeil K., Wreghitt T., and Wallwork J. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. J Heart Lung Transplant 22 (2003) 287-291
9. Gutierrez C.A., Chaparro C., Krajden M., Winton T., and Kesten S. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 113 (1998) 924-932
10. Glanville A.R., Valentine V.G., and Aboyoun C.L. CMV mismatch is not a risk factor for survival or severe bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 23 2 Suppl (2004) S43 (abstract)
11. Zamora M.R., Nicolls M.R., Hodges T.N., et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant 4 (2004) 1635-1642
12. Kroshus T.J., Kshettry V.R., Savik K., John R., Hertz M.I., and Bolman III R.M. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 114 (1997) 195-202
13. Keenan R.J., Lega M.E., Dummer J.S., et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51 (1991) 433-438
14. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. N Engl J Med 338 (1998) 1741-1751
15. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Lung and Heart-Lung Transplant Report-2005. J Heart Lung Transplant 24 (2005) 956-967